Broker Forsyth Barr has released the first comprehensive report into Dunedin-based biotech company Pacific Edge [NZX: PEB], and its outlook is positive, pleasing one investor Aaron Bhatnagar.

The New Zealand maker of non-invasive bladder cancer test kits Cxbladder has just launched a local online ordering service and has high hopes to dominate the US market.